Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

AHU-377alpha-phenethylamine salt polycrystalline type and preparation method and application thereof

A technology of AHU-377, phenethylamine salt, applied in the field of medicine, can solve the problems of difficult storage and weighing, poor quality of AHU-377 products, unfavorable storage and other problems

Inactive Publication Date: 2016-03-02
SHANGHAI HANSOH BIOMEDICAL +1
View PDF6 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] U.S. Patent US5217996 Example 1 reports that its 2-methyl usually exists in the form of a pair of diastereomers (R- or S-configuration), AHU-377 and 2S-methyl diastereomers The ratio of AHU-377 is about 80:20. In the actual production and preparation process, AHU-377 usually appears as oil, which is not conducive to its separation and purification, subsequent formulation development and storage
AHU-377 crude product is esterified with tert-butanol and hydrolyzed with sodium hydroxide, and the aggregation state of AHU-377 sodium salt obtained after dichloromethane / n-hexane recrystallization is unknown, and the inventors found that AHU-377 sodium salt after in-depth research The hygroscopicity is quite large, the substance is unstable and not conducive to storage. Therefore, AHU-377, as an active ingredient of a drug, has great problems in product quality, substance stability, storage or weighing, etc., and its sodium salt has not solved the above problems , although patents US5217996 and WO2007056546 both disclose that AHU-377 can also be prepared into various salt compounds, such as alkali metal salts, alkaline earth metal salts, amine salts, alkylamine salts, hydroxyalkylamine salts, etc., but mainly It is inferred from the chemical structure of AHU-377 that contains a carboxyl group that various salt compounds other than sodium salt have not been actually obtained, which cannot solve the problem of poor product quality, unstable substances, and difficulty in storage and weighing of AHU-377. And other issues
In addition, the application of this drug is for patients with hypertension and heart failure-like cardiovascular diseases, and sodium intake will also increase cardiovascular burden, so it is very necessary to replace sodium salts with salts that do not contain sodium ions, or Other types of salts that are not harmful or beneficial to cardiovascular

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • AHU-377alpha-phenethylamine salt polycrystalline type and preparation method and application thereof
  • AHU-377alpha-phenethylamine salt polycrystalline type and preparation method and application thereof
  • AHU-377alpha-phenethylamine salt polycrystalline type and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0068] Weigh 20mg (0.049mmol) of AHU-377 free acid (oil) into a 5.0mL glass bottle, add 1.0mL isopropyl acetate, stir to dissolve, add 5.9mg (0.049mmol) (R)-(+)- α-Phenylethylamine, continue to stir and react for 48 hours, collect the AHU-377(R)-(+)-α-Phenylethylamine salt crystal form obtained by collecting the reaction product, and its powder X-ray diffraction pattern is as follows figure 1 As shown, melting point: 126.6°C (onset point) as figure 2 shown.

Embodiment 2

[0070] Weigh 20mg (0.049mmol) of AHU-377 free acid (oil) into a 5.0mL glass bottle, add 0.4mL of isopropanol, stir to dissolve, add 6.5mg (0.053mmol) of (R)-(+)-α -Phenylethylamine, continue to stir and react for 48 hours, collect the AHU-377 (R)-(+)-alpha-phenethylamine crystal form obtained by the reaction product, its powder X-ray diffraction pattern is basically the same as figure 1 unanimous.

Embodiment 3

[0072] Weigh 20mg (0.049mmol) of AHU-377 free acid (oil) into a 5.0mL glass bottle, add 0.2mL methyl tert-butyl ether, heat to 50°C and stir to dissolve, add 5.9mg (0.049mmol) (R )-(+)-α-phenylethylamine, lower the temperature to room temperature (20-25°C) and continue stirring for 48 hours, and collect the AHU-377(R)-(+)-α-phenylethylamine salt crystals obtained from the reaction product type, its powder X-ray diffraction pattern is basically the same as figure 1 unanimous.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses AHU-377alpha-phenethylamine salt polycrystalline type and a preparation method and application thereof and particularly discloses the AHU-377alpha-phenethylamine salt polycrystalline type. An X-radial powder diffraction pattern comprises peaks located at the diffraction angles 2 theta, namely 20.58 + / -0.2 degrees, 24.28 + / -0.2 degrees, 8.38 + / - 0.2 degrees and 23.20 + / -0.2 degrees or peaks located at the diffraction angles 2 theta, namely 23.28+ / -0.2 degrees, 18.9+ / -0.2 degrees, 13.7+ / -0.2 degrees and 14.72+ / -0.2 degrees. The AHU-377 is prepared into the phenethylamine salt to change the physicochemical properties of the AHU-377, such as crystallinity, solubleness and hygroscopicity. The AHU-377alpha-phenethylamine salt polycrystalline type and the preparation method and application thereof are mature in process and high in operability, the obtained product is high in quality, homogeneous and stable, chemical stability is achieved, storage is facilitated, and wide application prospect is achieved.

Description

technical field [0001] The invention belongs to the technical field of medicines, and in particular relates to a NEP inhibitor AHU-377α-phenethylamine salt crystal form and a preparation method and application thereof. Background technique [0002] Neutral endopeptidase (EC 3.4.24.11; neprilysin; neprilysin; NEP) is a zinc-containing metalloprotease that cleaves various peptide substrates at the amino terminus of aromatic amino acids. Substrates for this enzyme include, but are not limited to, atrial natriuretic peptide (ANF, also known as ANP), brain natriuretic peptide (BNP), met and leu enkephalins, bradykinin, neurokinin A and substance P. [0003] ANF ​​is a family of vasodilatory, diuretic and antihypertensive peptides, and one form, ANF99-126, is a circulating peptide hormone released by the heart during cardiac dilation. The function of ANF is to maintain salt and water homeostasis and to regulate blood pressure. ANF ​​is rapidly inactivated in circulation by at le...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C231/24C07C233/47C07C209/86C07C211/27A61K31/225A61P9/12A61P9/04A61P9/00A61P9/06A61P9/10A61P13/12A61P25/06A61P25/28A61P25/00A61P27/02A61P27/06
Inventor 李响张磊龚素娟
Owner SHANGHAI HANSOH BIOMEDICAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products